Reaktionsgleichung
[N:1]1([C:7]2[N:12]=[CH:11][CH:10]=[CH:9][N:8]=2)[CH2:6][CH2:5][NH:4][CH2:3][CH2:2]1.[C:13]1([C:19]2[N:20]([CH2:30][C:31](O)=[O:32])[CH:21]=[C:22]([C:24]3[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=3)[N:23]=2)[CH:18]=[CH:17][CH:16]=[CH:15][CH:14]=1.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.[B-](F)(F)(F)F>CN(C=O)C>[C:13]1([C:19]2[N:20]([CH2:30][C:31]([N:4]3[CH2:5][CH2:6][N:1]([C:7]4[N:8]=[CH:9][CH:10]=[CH:11][N:12]=4)[CH2:2][CH2:3]3)=[O:32])[CH:21]=[C:22]([C:24]3[CH:25]=[CH:26][CH:27]=[CH:28][CH:29]=3)[N:23]=2)[CH:14]=[CH:15][CH:16]=[CH:17][CH:18]=1Komponenten
5
Edukt 3
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
40 mg 2-piperazin-1-yl-pyrimidine was added to 70 mg (2,4-diphenyl-imidazol-1-yl)-acetic acid, 80 mg TBTU, 50 μL TEA in 1 mL DMF. The reaction was stirred overnight at RT. The mixture was purified by HPLC to give 50 mg desired product.
Aufarbeitung
- customThe mixture was purified by HPLC
Quellen und Nachweise
- ORD-Eintrag
- ord-000f2c008bf444348603f18d2754f9fe
- Quelldatensatz
- uspto-grants-2014_09
- Patentnummer
- US08846948B2
Verknüpfte Notizen
Wird geladen…